Isabelle has served as a member of Enterome’s Board since 2008. CEO and Managing Partner of Seventure Partners where she launched Health for Life Capital™, the first European investment vehicle to support the microbiome revolution. Isabelle leads the lifesciences team and personally invests in biotech, nutrition & healthcare. Prior to joining Seventure in 2001, she managed multiple international deals at Pfizer and Fournier/Abbott at Business Development positions and began her career in 1991 with Arthur Andersen in Detroit, USA. Isabelle also serves as director on the Board of Limm Therapeutics,Ysopia, TargEDys, Polaris and Maat Pharma SA.

Isabelle has a degree in Engineering from French Ecole Centrale Paris and holds DECF and ISEB degrees.